Stellenbosch, South Africa

Biocode Technologies

Completed

Health

South Africa

GIZ

Biocode Technologies is a health diagnostics company focusing on developing, scaling, and clinically validating microclot detection rapid test for Long COVID and other cardiovascular diseases, through partnerships with clinical diagnostics and healthcare providers.

Investment

Country: South Africa
Public found: EUR 100,000
Start of Funding: 12/2024
Public Partner: GIZ

Impact

Good Health and Well-being

Reduced Inequalities

Apply Now

develoPPP Ventures

develoPPP Ventures is aimed at young companies with an innovative business model that are active in an emerging market and want to take the next step. Through a matching funds model, the program offers public early-stage investment support.

Apply Now

More Information

Go to Biocode Technologies

Go to GIZ

Do you have any questions?

For general questions regarding develoPPP or other BMZ funding programmes, please contact

Ulrich Boysen Senior Consultant Agency for Business & Economic Development

Hans-Joachim Hebgen Senior Consultant Agency for Business & Economic Development

For questions regarding already concrete projects please contact the team of your implementing partner

Daniel Thomann Head of Programme DEG Impulse gGmbH

Anja Meinecke Head of Programme Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH

Jonas Naguib Head of Programme Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH